复合冠状动脉血运重建术临床结果的研究进展  

Research progress on clinical outcomes of hybrid coronary revascularization

作　　者：李东杰 高杰[1] 苏丕雄[1] LI Dongjie;GAO Jie;SU Pixiong(Department of Cardiac Surgery,Heart Center,Chaoyang Hospital,Capital Medical University,Beijing,100020,P.R.China)

机构地区：[1]首都医科大学附属北京朝阳医院心脏外科,北京100020

出　　处：《中国胸心血管外科临床杂志》2021年第6期645-649,共5页Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

基　　金：北京市科委基金(Z191100006619036)。

摘　　要：复合冠状动脉血运重建术(hybrid coronary revascularization,HCR)结合了外科微创冠状动脉旁路移植术(minimally invasive direct coronary artery bypass grafting,MIDCAB)和内科经皮冠状动脉介入术(percutaneous coronary intervention,PCI)的优势,又避免了其相对不足,近年来受到内外科医生的广泛关注。HCR似乎已经成为冠状动脉粥样硬化性心脏病多支血管病变的第三种血运重建策略。但目前关于HCR的临床研究仍然有限,本文将对HCR与冠状动脉旁路移植术(coronary artery bypass grafting,CABG)和PCI的比较、HCR在特定患者中的结果、不同HCR策略的临床结果等做系统综述。Hybrid coronary revascularization(HCR)combines the advantages of minimally invasive direct coronary artery bypass grafting(MIDCAB)and percutaneous coronary intervention(PCI),and avoids its relative shortcomings,which has received particular attention in recent years.HCR seems to have become the third revascularization strategy for multi-vessel disease in coronary heart diseases.However,the clinical researches on HCR are still limited.This article will systematically review the comparison of HCR with coronary artery bypass grafting(CABG)and PCI,the results of HCR in specific patients,and the clinical results of different HCR strategies.

关 键 词：复合冠状动脉血运重建术 冠状动脉旁路移植术 经皮冠状动脉介入术 微创冠状动脉旁路移植术 综述 

分 类 号：R541.4[医药卫生—心血管疾病]